1. Home
  2. Live Updates
  3. Orphan drug

Orphan Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Orphan drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Orphan Drug Today - Breaking & Trending Today

Tafenoquine Gets Orphan Drug Status for Acute Babesiosis

Babesiosis is an infectious disease caused by microscopic parasites, Babesia, that infect red blood cells. ....

United States , Tufts Medical Center , Geoff Dow , Drug Administration , Degrees Pharmaceuticals , Orphan Drug ,

Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate

BioPharma ....

United States , David Thompson , Zimmer Biomet , Jjdc Inc , Osteal Therapeutics Inc , Johnson Innovation , Gideon Strategic Partners , Osteal Therapeutics , New Drug Application , Orphan Drug , Fast Track , Qualified Infectious Disease Product , Chief Executive , Periprosthetic Joint Infection ,

Novel Antifibrotic Gets Orphan Drug Status for Idiopathic Pulmonary Fibrosis

The FDA has granted Orphan Drug designation to AGMB-447 for the treatment of idiopathic pulmonary fibrosis. ....

Philippe Wiesel , Drug Administration , Orphan Drug , Chief Medical Officer ,

Engineered B Cell Medicine Gets Orphan Drug Status for Hemophilia B

BE-101 is a potential first-in-class B cell medicine engineered to insert the human FIX gene into primary human B cells. ....

Joanne Smith Farrell , Drug Administration , Orphan Drug ,

Functional Improvement Seen With C1q Inhibitor in Guillain-Barré Syndrome

ANX005 is a C1q inhibitor that is administered intravenously and works by blocking the activation of classical complement pathway. ....

International Guillain Barr , Drug Administration , Research Council , Peripheral Nerve Society Annual Meeting On , Medical Research Council , Douglas Love , Western International Guillain Barr , Syndrome Outcomes Study , Biologics License Application , Nerve Society Annual Meeting , Fast Track , Orphan Drug ,